Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    The Avandia debate.

    Bloomgarden ZT.

    Diabetes Care. 2007 Sep;30(9):2401-8. No abstract available. PMID: 17726191 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.

    [No authors listed]

    Harv Heart Lett. 2007 Aug;17(12):1-2. No abstract available. PMID: 17717888 [PubMed - indexed for MEDLINE]Related articles

    3.

    Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007.

    Boyle P.

    South Med J. 2007 Nov;100(11):1063-4. No abstract available. PMID: 17984728 [PubMed - indexed for MEDLINE]Related articles

    4.

    The Avandia debacle: methodology and practical importance of the findings.

    Meneghini LF, Florez H, Tamariz L.

    South Med J. 2007 Nov;100(11):1062-3. No abstract available. PMID: 17984727 [PubMed - indexed for MEDLINE]Related articles

    5.

    Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.

    Psaty B.

    US News World Rep. 2007 Jun 4;142(20):64. No abstract available. PMID: 17632813 [PubMed - indexed for MEDLINE]Related articles

    6.

    Avandia in perspective.

    Comarow A.

    US News World Rep. 2007 Oct 1;143(11):71. No abstract available. PMID: 17957906 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rosiglitazone and cardiovascular risk.

    Mannucci E, Monami M, Marchionni N.

    N Engl J Med. 2007 Aug 30;357(9):938; author reply 939-40. No abstract available. PMID: 17806136 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rosiglitazone and cardiovascular risk.

    Diamond GA, Kaul S.

    N Engl J Med. 2007 Aug 30;357(9):938-9; author reply 939-40. No abstract available. PMID: 17806135 [PubMed - indexed for MEDLINE]Related articles

    9.

    Drug safety. Heart attack risk overshadows a popular diabetes therapy.

    Couzin J.

    Science. 2007 Jun 15;316(5831):1550-1. No abstract available. PMID: 17569830 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rosiglitazone: a thunderstorm from scarce and fragile data.

    Mulrow CD, Cornell J, Localio AR.

    Ann Intern Med. 2007 Oct 16;147(8):585-7. No abstract available. PMID: 17938398 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Rosiglitazone and cardiovascular risk.

    Bracken MB.

    N Engl J Med. 2007 Aug 30;357(9):937-8; author reply 939-40. No abstract available. PMID: 17761600 [PubMed - indexed for MEDLINE]Related articles

    12.

    The record on rosiglitazone and the risk of myocardial infarction.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jul 5;357(1):67-9. Epub 2007 Jun 5. No abstract available. PMID: 17551162 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rosiglitazone--continued uncertainty about safety.

    Drazen JM, Morrissey S, Curfman GD.

    N Engl J Med. 2007 Jul 5;357(1):63-4. Epub 2007 Jun 5. No abstract available. PMID: 17551160 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rosiglitazone and cardiovascular risk.

    Kaul S, Diamond GA.

    Curr Atheroscler Rep. 2008 Oct;10(5):398-404. Review.PMID: 18706281 [PubMed - indexed for MEDLINE]Related articles

    15.

    Faster publication isn't always better.

    Fuster V, Farkouh ME.

    Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):345. No abstract available. PMID: 17589426 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rosiglitazone and cardiovascular risk.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jun 14;356(24):2522-4. Epub 2007 May 21. No abstract available. PMID: 17517854 [PubMed - indexed for MEDLINE]Related articles

    17.

    Rosiglitazone and cardiovascular disease: a cardiologist's perspective.

    Marx N.

    Diab Vasc Dis Res. 2007 Jun;4(2):80-1. No abstract available. PMID: 17654439 [PubMed - indexed for MEDLINE]Related articles

    18.

    Thiazolidinediones, deadly sins, surrogates, and elephants.

    Cleland JG, Atkin SL.

    Lancet. 2007 Sep 29;370(9593):1103-4. No abstract available. PMID: 17905146 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rosiglitazone and cardiovascular disease: an epidemiologist's perspective.

    McGuire DK.

    Diab Vasc Dis Res. 2007 Jun;4(2):77-9. No abstract available. PMID: 17654438 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cardiovascular safety of rosiglitazone.

    Krall RL.

    Lancet. 2007 Jun 16;369(9578):1995-6. No abstract available. PMID: 17574083 [PubMed - indexed for MEDLINE]Related articles